Subutex 300 mg injektionsvätska, depotlösning, Subutex 100 mg injektionsvätska, depotlösning
INDV-6000-406
Approved small_molecule active
Quick answer
Subutex 300 mg injektionsvätska, depotlösning, Subutex 100 mg injektionsvätska, depotlösning for Opioid Use Disorder is a Approved program (small_molecule) at Indivior Europe Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Indivior Europe Limited
- Indication
- Opioid Use Disorder
- Phase
- Approved
- Modality
- small_molecule
- Status
- active